Kidron H - Search Results

1

A critical assessment of in vitro tissue models for ADME and drug delivery.

Vellonen KS, Malinen M, Mannermaa E, Subrizi A, Toropainen E, Lou YR, Kidron H, Yliperttula M, Urtti A. Vellonen KS, et al. Among authors: kidron h. J Control Release. 2014 Sep 28;190:94-114. doi: 10.1016/j.jconrel.2014.06.044. Epub 2014 Jun 30. J Control Release. 2014. PMID: 24993429 Review.

2

Prediction of the corneal permeability of drug-like compounds.

Kidron H, Vellonen KS, del Amo EM, Tissari A, Urtti A. Kidron H, et al. Pharm Res. 2010 Jul;27(7):1398-407. doi: 10.1007/s11095-010-0132-8. Epub 2010 Apr 13. Pharm Res. 2010. PMID: 20387098

3

Impact of probe compound in MRP2 vesicular transport assays.

Kidron H, Wissel G, Manevski N, Häkli M, Ketola RA, Finel M, Yliperttula M, Xhaard H, Urtti A. Kidron H, et al. Eur J Pharm Sci. 2012 May 12;46(1-2):100-5. doi: 10.1016/j.ejps.2012.02.016. Epub 2012 Mar 3. Eur J Pharm Sci. 2012. PMID: 22406294

4

Prediction of the vitreal half-life of small molecular drug-like compounds.

Kidron H, Del Amo EM, Vellonen KS, Urtti A. Kidron H, et al. Pharm Res. 2012 Dec;29(12):3302-11. doi: 10.1007/s11095-012-0822-5. Epub 2012 Jul 10. Pharm Res. 2012. PMID: 22777295

5

Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.

Sjöstedt N, Kortejärvi H, Kidron H, Vellonen KS, Urtti A, Yliperttula M. Sjöstedt N, et al. Among authors: kidron h. Pharm Res. 2014 Jan;31(1):1-19. doi: 10.1007/s11095-013-1124-2. Pharm Res. 2014. PMID: 23797466 Review.

6

Applying linear and non-linear methods for parallel prediction of volume of distribution and fraction of unbound drug.

del Amo EM, Ghemtio L, Xhaard H, Yliperttula M, Urtti A, Kidron H. del Amo EM, et al. Among authors: kidron h. PLoS One. 2013 Oct 7;8(10):e74758. doi: 10.1371/journal.pone.0074758. eCollection 2013. PLoS One. 2013. PMID: 24116008 Free PMC article.

7

Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development.

del Amo EM, Vellonen KS, Kidron H, Urtti A. del Amo EM, et al. Among authors: kidron h. Eur J Pharm Biopharm. 2015 Sep;95(Pt B):215-26. doi: 10.1016/j.ejpb.2015.01.003. Epub 2015 Jan 17. Eur J Pharm Biopharm. 2015. PMID: 25603198

8

Exploring the structure-activity relationships of ABCC2 modulators using a screening approach.

Wissel G, Kudryavtsev P, Ghemtio L, Tammela P, Wipf P, Yliperttula M, Finel M, Urtti A, Kidron H, Xhaard H. Wissel G, et al. Among authors: kidron h. Bioorg Med Chem. 2015 Jul 1;23(13):3513-25. doi: 10.1016/j.bmc.2015.04.029. Epub 2015 Apr 17. Bioorg Med Chem. 2015. PMID: 25935289 Free PMC article.

9

Correction: Applying Linear and Non-Linear Methods for Parallel Prediction of Volume of Distribution and Fraction of Unbound Drug.

Del Amo EM, Ghemtio L, Xhaard H, Yliperttula M, Urtti A, Kidron H. Del Amo EM, et al. Among authors: kidron h. PLoS One. 2015 Oct 28;10(10):e0141943. doi: 10.1371/journal.pone.0141943. eCollection 2015. PLoS One. 2015. PMID: 26509808 Free PMC article. No abstract available.

10

General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.

Deng F, Ranta VP, Kidron H, Urtti A. Deng F, et al. Among authors: kidron h. Pharm Res. 2016 Nov;33(11):2680-90. doi: 10.1007/s11095-016-1993-2. Epub 2016 Jul 18. Pharm Res. 2016. PMID: 27431864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page